EFFECT OF NALTREXONE-BUPROPION ON MAJOR ADVERSE CARDIOVASCULAR EVENTS IN OVERWEIGHT AND OBESE PATIENTS WITH CARDIOVASCULAR RISK FACTORS- A RANDOMIZED CLINICAL TRIAL